See veebileht kasutab küpsiseid kasutaja sessiooni andmete hoidmiseks. Veebilehe kasutamisega nõustute ETISe kasutustingimustega. Loe rohkem
Olen nõus
"Horisont 2020 programm" projekt MP1GV15102R
MP1GV15102R "BBMRI-ERIC'u kui tervise portaali rakendamine (1.08.2015−31.07.2018)", Andres Metspalu, Tartu Ülikool, Tartu Ülikooli Eesti Geenivaramu.
MP1GV15102R
BBMRI-ERIC'u kui tervise portaali rakendamine
ImplementAtion anDOPeration of the gateway for healTh into BBMRI-ERIC
1.08.2015
31.07.2018
Teadus- ja arendusprojekt
Horisont 2020 programm
ValdkondAlamvaldkondCERCS erialaFrascati Manual’i erialaProtsent
3. Terviseuuringud3.1. BiomeditsiinB726 Kliiniline bioloogia 3.1. Biomeditsiin (anatoomia, tsütoloogia, füsioloogia, geneetika, farmaatsia, farmakoloogia, kliiniline keemia, kliiniline mikrobioloogia, patoloogia)100,0
AsutusRiikTüüp
Euroopa Komisjon
PerioodSumma
01.08.2015−31.07.201866 162,50 EUR
66 162,50 EUR

ADOPT BBMRI-ERIC
BBMRI-ERIC: the Biobanking and BioMolecular resources Research Infrastructure - European Research Infrastructure Consortium, aims to establish, operate and develop a Pan-European distributed research infrastructure in order to facilitate the access to biological resources as well as facilities and to support high quality biomolecular and biomedical research. The ADOPT BBMRI-ERIC proposal aims at boosting and accelerating implementation of BBMRI-ERIC and its services. Its main deliverables are designed to complete or launch the construction of key Common Services of the Research Infrastructure as required for ESFRI-projects "underimplementation", reflecting the targets of the European Research Area (ERA). One of the challenges in the post-genomic era is the research on common complex diseases, such as cancer, diabetes and Alzheimer^s disease. Revealing these diseases will depend critically on the study of human biological samples and data from large numbers of patients and healthy individuals. The EU's ageing population is will result in an increase in many of those diseases and consequently an increased healthcare expenditure for senior citizens. BBMRI-ERIC is a specific European asset having become a fundamental component in addressing the ongoing and future requirements particularly of Europe's health service frameworks, including competitiveness and innovativeness of health related industries. Its implementation is essential for the understanding of the diversity of human diseases, biological samples and corresponding data, which are required for the development of any new drug or diagnostic assay and are, therefore, critical for the advancement in health research, ultimately leading to personalised medicine. BBMRI-ERIC will provide a gateway access to the collections of the European research community, expertise and services building on the outcome of ADOPT BBMRI-ERIC.
TegevusProtsent
Alusuuring75,0
Rakendusuuring25,0